Uncategorized
Health Canada approves use of iStent inject
Health Canada has approved iStent inject to be used as standalone procedure or in conjunction with cataract surgery to reduce IOP, according to a Glaukos press release.The approval is for reduction of IOP in patients diagnosed with primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma, the release said.